Logo image
Sign in
Quality-adjusted time without symptom or toxicity and quality-adjusted progression-free survival of first-line maintenance niraparib in patients with advanced ovarian cancer
Conference proceeding   Open access

Quality-adjusted time without symptom or toxicity and quality-adjusted progression-free survival of first-line maintenance niraparib in patients with advanced ovarian cancer

Pilar Barretina-Ginesta, Bradley J. Monk, Sileny Han, Bhavana Pothuri, Annika Auranen, Dana M. Chase, Domenica Lorusso, Charles Anderson, Sophie Abadie-Lacourtoisie, Noelle Cloven, …
Proceedings of the 7th Biennial Meeting of Asian Society of Gynecologic Oncology
01/01/2021
url
https://doi.org/10.3802/jgo.2021.32.s1.oo8View
Published (Version of record) Open

Metrics

3 Record Views

Details